- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 31/12 - Antivirals
Patent holdings for IPC class A61P 31/12
Total number of patents in this class: 7813
10-year publication summary
|
311
|
267
|
331
|
377
|
461
|
913
|
934
|
631
|
386
|
33
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gilead Sciences, Inc. | 1951 |
128 |
| Bristol-myers Squibb Company | 4865 |
90 |
| F. Hoffmann-La Roche AG | 7938 |
88 |
| The Regents of the University of California | 19503 |
63 |
| Emory University | 1588 |
59 |
| Hoffmann-La Roche Inc. | 3262 |
51 |
| Centre National de La Recherche Scientifique | 10091 |
47 |
| Novartis AG | 11276 |
43 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2832 |
35 |
| Janssen Sciences Ireland Unlimited Company | 435 |
33 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 669 |
32 |
| Katholieke Universiteit Leuven | 1105 |
31 |
| The Johns Hopkins University | 5529 |
27 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2608 |
27 |
| Janssen Sciences Ireland UC | 242 |
27 |
| President and Fellows of Harvard College | 5911 |
26 |
| Merck Sharp & Dohme Corp. | 2219 |
25 |
| The Board of Trustees of the Leland Stanford Junior University | 6239 |
24 |
| Intervet International B.V. | 1282 |
24 |
| Sunshine Lake Pharma Co., Ltd. | 570 |
23 |
| Other owners | 6910 |